Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7B6W

Crystal structure of the human alpha1B adrenergic receptor in complex with inverse agonist (+)-cyclazosin

This is a non-PDB format compatible entry.
Summary for 7B6W
Entry DOI10.2210/pdb7b6w/pdb
DescriptorAlpha-1B adrenergic receptor,alpha1B adrenergic receptor,Alpha-1B adrenergic receptor,alpha1B adrenergic receptor,Alpha-1B adrenergic receptor,alpha1B adrenergic receptor,Alpha-1B adrenergic receptor,alpha1B adrenergic receptor, [(4~{a}~{R},8~{a}~{S})-4-(4-azanyl-6,7-dimethoxy-quinazolin-2-yl)-2,3,4~{a},5,6,7,8,8~{a}-octahydroquinoxalin-1-yl]-(furan-2-yl)methanone (2 entities in total)
Functional Keywordsgpcr-ligand complex, alpha1b adrenergic receptor, cyclazosin, inverse agonist, membrane protein
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains1
Total formula weight50880.41
Authors
Deluigi, M.,Morstein, L.,Hilge, M.,Schuster, M.,Merklinger, L.,Klipp, A.,Scott, D.J.,Plueckthun, A. (deposition date: 2020-12-08, release date: 2022-01-12, Last modification date: 2024-11-20)
Primary citationDeluigi, M.,Morstein, L.,Schuster, M.,Klenk, C.,Merklinger, L.,Cridge, R.R.,de Zhang, L.A.,Klipp, A.,Vacca, S.,Vaid, T.M.,Mittl, P.R.E.,Egloff, P.,Eberle, S.A.,Zerbe, O.,Chalmers, D.K.,Scott, D.J.,Pluckthun, A.
Crystal structure of the alpha 1B -adrenergic receptor reveals molecular determinants of selective ligand recognition.
Nat Commun, 13:382-382, 2022
Cited by
PubMed Abstract: α-adrenergic receptors (αARs) are G protein-coupled receptors that regulate vital functions of the cardiovascular and nervous systems. The therapeutic potential of αARs, however, is largely unexploited and hampered by the scarcity of subtype-selective ligands. Moreover, several aminergic drugs either show off-target binding to αARs or fail to interact with the desired subtype. Here, we report the crystal structure of human αAR bound to the inverse agonist (+)-cyclazosin, enabled by the fusion to a DARPin crystallization chaperone. The αAR structure allows the identification of two unique secondary binding pockets. By structural comparison of αAR with αARs, and by constructing αAR-αAR chimeras, we identify residues 3.29 and 6.55 as key determinants of ligand selectivity. Our findings provide a basis for discovery of αAR-selective ligands and may guide the optimization of aminergic drugs to prevent off-target binding to αARs, or to elicit a selective interaction with the desired subtype.
PubMed: 35046410
DOI: 10.1038/s41467-021-27911-3
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.873 Å)
Structure validation

235666

PDB entries from 2025-05-07

PDB statisticsPDBj update infoContact PDBjnumon